Search is restricted to the following diseases:
Search Results for "RIPK2" - 16 interactions found in 6 entries.
|
|
|
Interactor1 (Subject) |
|
Interaction type |
Interactor2 (Object) |
additional information |
|
|
|
|
6,817
|
| 66312 |
NOD2
|
|
interacts (colocalizes) with
|
RIPK2
|
in HEK293T cells
|
|
11087742
|
Metabolic
Inflammation
|
|
6,972
|
| 68383 |
NOD2
|
|
interacts (colocalizes) with
|
RIPK2
|
if NOD2 has been activated by N-acetyl muramyl dipeptide (MDP), a component of bacterial peptidoglycan.
|
| 68406 |
RIPK2
|
|
is_part_of
|
NOD2-RIPK2
|
|
|
21252204
|
Inflammatory bowel disease
|
|
7,048
|
| 69129 |
XIAP
|
|
interacts (colocalizes) with
|
RIPK2
|
in HEK293T cells and THP-1 monocytes
|
|
|
Inflammation
|
|
7,049
|
| 69189 |
XIAP
|
|
interacts (colocalizes) with
|
RIPK2
|
|
| 69191 |
XIAP
|
|
increases_ubiquitination/sumoylation of
|
RIPK2
|
in THP-1 cells
|
| 69193 |
BIRC2
|
|
increases_ubiquitination/sumoylation of
|
RIPK2
|
in HCT-116 cells ; together with BIRC3 and XIAP
|
| 69194 |
BIRC3
|
|
increases_ubiquitination/sumoylation of
|
RIPK2
|
in HCT-116 cells ; together with BIRC2 and XIAP
|
| 69312 |
RIPK2
|
|
increases_activity of
|
LUBAC complex
|
in HCT-116 cells
|
|
|
Inflammatory bowel disease
Inflammation
|
|
7,082
|
| 69631 |
SPATA2
|
|
decreases_ubiquitination/sumoylation of
|
RIPK2
|
in U2OS cells; via linking CYLD to RIPK2
|
| 69649 |
SPATA2-CYLD complex
|
|
decreases_ubiquitination/sumoylation of
|
RIPK2
|
in U2OS cells; via linking CYLD to RIPK2
|
| 69655 |
SPATA2-CYLD complex
|
|
decreases_activity of
|
RIPK2
|
in U2OS cells; via linking CYLD to RIPK2 resulting in decreased NOD2 signaling
|
| 69669 |
CYLD
|
|
decreases_ubiquitination/sumoylation of
|
RIPK2
|
in U2OS cells
|
| 69670 |
CYLD
|
|
decreases_activity of
|
RIPK2
|
in U2OS cells
|
|
|
Inflammation
|
|
12,590
|
| 122300 |
PELI3
|
|
interacts (colocalizes) with
|
RIPK2
|
in HEK293 cells
|
| 122301 |
PELI3
|
|
increases_ubiquitination/sumoylation of
|
RIPK2
|
in HEK293 cells
|
|
23892723
|
Inflammation
|
CIDeRplus